{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:03Z","timestamp":1790223123466,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.contraception.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T09:13:10Z","timestamp":1298365990000},"page":"133-143","source":"Crossref","is-referenced-by-count":25,"title":["Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy"],"prefix":"10.1016","volume":"84","author":[{"given":"Inka","family":"Wiegratz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skadi","family":"Stahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Manthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"S\u00e4nger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Mittmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Mellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesta","family":"Palombo-Kinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.01.002_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2005.09.009","article-title":"Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use","volume":"73","author":"Birtch","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 mcg) and ethinyl estradiol (15 mcg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.01.002_bb0020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(99)00043-8","article-title":"Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use","volume":"59","author":"den Tonkelaar","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0029-7844(99)00524-4","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Extended-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0040","first-page":"162","article-title":"Avoiding menstruation. A review of health and lifestyle issues","volume":"49","author":"Henzl","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2011.01.002_bb0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2217\/17455057.2.5.705","article-title":"Extended and continuous use of hormonal contraceptives to reduce menstruation","volume":"2","author":"Wiegratz","year":"2006","journal-title":"Women's Health"},{"key":"10.1016\/j.contraception.2011.01.002_bb0050","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.contraception.2007.02.005","article-title":"Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women","volume":"75","author":"Edelman","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajog.2005.12.045","article-title":"Extended-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial","volume":"195","author":"Anderson","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.contraception.2006.10.009","article-title":"Bleeding patterns of women using extended regimens of the contraceptive vaginal ring","volume":"75","author":"Barreiros","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2009.05.004","article-title":"Extended regimens of the vaginal contraceptive ring: cycle control","volume":"80","author":"Guazzelli","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0029-7844(03)00014-0","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0090","unstructured":"IMS\u00ae-DPM Sales Analyzer, http:\/\/www.imshealth.de"},{"key":"10.1016\/j.contraception.2011.01.002_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13625180701441121","article-title":"Evaluation of menstrual bleeding patterns: a new proposal for a universal guideline based on the analysis of more than 4500 bleeding diaries","volume":"12","author":"Gerlinger","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.01.002_bb0100","author":"European Medicines Agency (EMEA)"},{"key":"10.1016\/j.contraception.2011.01.002_bb0105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.whi.2004.08.005","article-title":"Evidence about extending the duration of oral contraceptive use to suppress menstruation","volume":"14","author":"Hitchcock","year":"2004","journal-title":"Women's Health Issues"},{"key":"10.1016\/j.contraception.2011.01.002_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2009.07.003","article-title":"The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol","volume":"81","author":"Kroll","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.contraception.2007.05.081","article-title":"Bleeding patterns associated with oral contraceptive use: a review of the literature","volume":"76","author":"Bachman","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraception discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0135","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.AOG.0000199950.64545.16","article-title":"Continuous oral contraceptives. Are bleeding patterns dependent on the hormones given?","volume":"107","author":"Edelman","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.contraception.2006.05.050","article-title":"Patient candidate evaluation for a low-dose continuous oral contraceptive","volume":"74","author":"Barnhart","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0145","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajog.2006.02.048","article-title":"Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen","volume":"195","author":"Sulak","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2004.07.013","article-title":"Endometrial microstructure after extended-term use of a 91-day extended-cycle oral contraceptive regimen","volume":"71","author":"Anderson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2006.07.009","article-title":"Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg","volume":"75","author":"Johnson","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.contraception.2005.06.068","article-title":"The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days","volume":"73","author":"Foidart","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0170","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2165\/00003495-200464210-00006","article-title":"Extended-cycle treatment with oral contraceptives","volume":"64","author":"Wiegratz","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2011.01.002_bb0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2006.02.006","article-title":"Greater inhibition of the pituitary-ovarian axis in oral contraceptive regimens with a shortened hormone-free interval","volume":"74","author":"Willis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0180","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(05)79442-3","article-title":"Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives","volume":"351","author":"de Bruijn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.01.002_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0190","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.01.002_bb0195","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/0002-9378(90)90560-T","article-title":"Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism","volume":"163","author":"Jung-Hoffmann","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.contraception.2008.06.015","article-title":"Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters","volume":"78","author":"Wiegratz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2008.02.005","article-title":"Effects of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use","volume":"77","author":"S\u00e4nger","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/s-0030-1248263","article-title":"Effects of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on carbohydrate metabolism during 1 year of conventional or extended-cycle use","volume":"42","author":"Wiegratz","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.contraception.2011.01.002_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.contraception.2009.07.011","article-title":"Effects of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use","volume":"81","author":"Wiegratz","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.01.002_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1160\/TH04-11-0759","article-title":"Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The TREATS Study","volume":"94","author":"Wu","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2011.01.002_bb0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","article-title":"Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms","volume":"89","author":"Sulak","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/dei377","article-title":"Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials","volume":"21","author":"Edelman","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.01.002_bb0235","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0240","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.01.002_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval","volume":"47","author":"Sulak","year":"2007","journal-title":"Headache"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411000035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411000035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T18:56:44Z","timestamp":1560020204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411000035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0010782411000035"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.01.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}